Rubric Capital Management (New York)’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,650,000
| Closed | -$495K | – | 78 |
|
|
2020
Q4 | $495K | Sell |
1,650,000
-716,965
| -30% | -$215K | 0.04% | 58 |
|
|
2020
Q3 | $5.33M | Sell |
2,366,965
-2,377,730
| -50% | -$5.35M | 0.5% | 49 |
|
|
2020
Q2 | $17M | Buy |
4,744,695
+2,109,501
| +80% | +$7.55M | 1.95% | 27 |
|
|
2020
Q1 | $10M | Buy |
2,635,194
+20,777
| +0.8% | +$79K | 1.58% | 25 |
|
|
2019
Q4 | $7.87M | Buy |
+2,614,417
| New | +$7.87M | 0.89% | 33 |
|